Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psoriasis skin and gut microbiota changes during systemic therapy with adalimumab, ustekinumab, or cyclosporine
2014-003022-40Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Oct 2014
- Modality
- Small Molecules, Peptides, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of adalimumab, ustekinumab and cyclosporine in psoriasis and plaque psoriasis (3 arms), sponsored by Universitätsklinikum Münster. Started Oct 2014; status: completed.
02
Drugs
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2014-003022-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003022-40.